震的评估和管理
Sydney Spagna1, Amy Ferng1, Kelvin Chou2
1Department of Neurology, University of Michigan, 1500 East Medical Center Drive SPC 5316, Ann Arbor, MI 48109, USA.
Primary care
|May 1, 2024
概括
这篇文章指导初级保健提供者诊断和管理,一个常见的条件. 它涵盖了检查技术,差异诊断,如帕金森病和基本震,以及治疗选择.
科学领域:
- 神经学 神经学
- 主要护理医学 医疗保健
背景情况:
- 震是初级保健中经常遇到的疾病.
- 它可以呈现为休息震,动作震,或组合.
- 关键的差异诊断包括帕金森病,基本震和药物诱导的震.
研究的目的:
- 为初级保健提供者提供一个检查患者的框架.
- 突出历史和检查特征有助于震诊断.
- 审查当前的治疗策略和适用于专家转诊的指示.
主要方法:
- 审查临床指南和相关文献.
- 在初级保健环境中讨论诊断方法.
- 综合有关震分类,病因和管理的信息.
主要成果:
- 具体的检查操作和历史问题对于区分震类型至关重要.
- 强调了对帕金森病,基本震和药物诱导的震的早期识别.
- 治疗因震类型而异,复杂或耐火病例需要转诊神经科医生.
结论:
- 在初级保健中有效的震管理依赖于系统的评估和有针对性的治疗.
- 了解关键诊断特征可以改善患者的治疗结果.
- 及时转诊神经病学可以确保在需要时提供专业护理.
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Anxiolytic Drugs: Overview
282
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
282
Myasthenia Gravis: Diagnostic Tests
800
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
800


